[EN] SULFONAMIDE ANALOGUES OF GALIELLALACTONE<br/>[FR] ANALOGUES DE SULFONAMIDE DE GALIELLALACTONE
申请人:GLACTONE PHARMA DEV AB
公开号:WO2018104295A1
公开(公告)日:2018-06-14
Disclosed are sulfonamide analogues of galiellactone of formula (I) as STAT3-inhibitors for use in the treatment of a STAT3 signaling related disorder, e.g. solid cancers, hematological cancers, benign tumors, hyperproliferative diseases, inflammations, autoimmune diseases, graft or transplant rejections, delayed physiological function of grafts or transplants, neurodegenerative diseases and viral infections. The sulfonamide comprises a cyclic substituent.
揭示了作为STAT3抑制剂的盖利拉克通的磺胺类似物的化学式(I),用于治疗与STAT3信号相关的疾病,例如实体癌症、血液系统癌症、良性肿瘤、过度增生性疾病、炎症、自身免疫疾病、移植或移植排斥反应、移植物或移植物的延迟生理功能、神经退行性疾病和病毒感染。磺胺类似物包括一个环状取代基。